Provided by Tiger Trade Technology Pte. Ltd.

Tyra Biosciences, Inc.

27.99
-1.2000-4.11%
Post-market: 27.990.00000.00%19:47 EST
Volume:481.52K
Turnover:13.82M
Market Cap:1.49B
PE:-14.89
High:30.26
Open:29.41
Low:27.82
Close:29.19
52wk High:33.99
52wk Low:6.42
Shares:53.37M
Float Shares:17.22M
Volume Ratio:0.51
T/O Rate:2.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8798
EPS(LYR):-1.5114
ROE:-34.75%
ROA:-23.08%
PB:5.33
PE(LYR):-18.52

Loading ...

Analysts Offer Insights on Healthcare Companies: Adagene (ADAG) and Tyra Bioscience (TYRA)

TIPRANKS
·
1 hour ago

Tyra Biosciences Chief Discovery Officer Daniel Bensen Reports Disposal of Common Shares

Reuters
·
Yesterday

Tyra Biosciences Advances TYRA-300 Bladder Cancer Trial: What Investors Should Watch

TIPRANKS
·
Yesterday

Tyra Biosciences Is Maintained at Outperform by Wedbush

Dow Jones
·
Feb 13

Wedbush Sticks to Its Buy Rating for Tyra Bioscience (TYRA)

TIPRANKS
·
Feb 13

Wedbush Raises Price Target on Tyra Bioscience to $53 From $37, Keeps Outperform Rating

MT Newswires Live
·
Feb 13

Tyra Biosciences participates in a coferejce call with William Blair

TIPRANKS
·
Feb 12

William Blair Initiates Tyra Bioscience at Outperform

MT Newswires Live
·
Feb 10

Analysts Offer Insights on Healthcare Companies: Tyra Bioscience (TYRA) and Novo Nordisk (NVO)

TIPRANKS
·
Feb 10

Tyra Biosciences Advances BEACH301 Dose Escalation

TIPRANKS
·
Feb 05

Tyra Bioscience (TYRA) Gets a Buy from Oppenheimer

TIPRANKS
·
Feb 03

Tyra Biosciences Is Maintained at Buy by Jefferies

Dow Jones
·
Feb 03

U.S. RESEARCH ROUNDUP-Adobe, Exxon Mobil, Stellar Bancorp

Reuters
·
Feb 03

Tyra Biosciences Initiated at Overweight by Barclays

Dow Jones
·
Jan 28

Tyra Biosciences initiated with an Overweight at Barclays

TIPRANKS
·
Jan 28

Tyra Biosciences Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Jan 23

Tyra Biosciences price target raised to $42 from $33 at Piper Sandler

TIPRANKS
·
Jan 23

Tyra Biosciences Inc : Piper Sandler Raises Target Price to $42 From $33

THOMSON REUTERS
·
Jan 23

How Investors May Respond To Tyra Biosciences (TYRA) Strengthening Its Leadership Team And Regulatory Focus

Simply Wall St.
·
Jan 22

Tyra Biosciences Chief Discovery Officer Daniel Bensen Reports Sale of Common Shares

Reuters
·
Jan 21